Stock listing
Lexicon Pharmaceuticals, Inc.
Selected listing: LXRX · NASDAQ · USD · US
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), Health Technology. Latest release Sep 25, 2026: LX-9211 Market Outlook 2026-2034 | Sales Forecast Highlights…
- Ticker
- NASDAQ:LXRX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Lexicon Pharmaceuticals, Inc.
The company focuses on developing innovative therapies for various diseases. Lexicon is committed to advancing its research and development efforts to improve patient outcomes.
Latest news from Lexicon Pharmaceuticals, Inc.
LX-9211 Market Outlook 2026-2034 | Sales Forecast Highlights Emerging Commercial Opportunities
September 25, 2026
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
September 1, 2026
Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure
August 31, 2026
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
August 24, 2026
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
August 7, 2026
Events
Research Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. company profile
View the public company page for Lexicon Pharmaceuticals, Inc. on 6ix.
Lexicon Pharmaceuticals, Inc. news
Read company news and market updates connected to Lexicon Pharmaceuticals, Inc..
Lexicon Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Lexicon Pharmaceuticals, Inc..